why choose us

First received: October 24, 2023

Clinical Trial: Metyrapone for Mild Autonomous Cortisol Secretion (MACS)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Autonomous Cortisol Secretion

Study Type: INTERVENTIONAL


Official Title: Metyrapone Intervention in Patients With Mild Autonomous Cortisol Secretion (MACS)

Brief Summary: The purpose of this study is to find out whether the study drug, metyrapone, is safe and effective in treating participants with Mild Autonomous Cortisol Secretion (MACS).

Read more